Bromperidol Explained

Bromperidol, sold under the brand names Bromidol and Impromen among others, is a typical antipsychotic of the butyrophenone group which is used in the treatment of schizophrenia.^{[1] [2]} It was discovered at Janssen Pharmaceutica in 1966. An ester prodrug, bromperidol decanoate, is a long-acting form of bromperidol used as a depot injectable.

Further reading

• Pöldinger W, Bures E, Haage H . Clinical study with bromperidol, a new butyrophenone derivative . International Pharmacopsychiatry . 12 . 1 . 20–4 . 1977 . 873716 . 10.1159/000468282 .
• Dubinsky B, McGuire JL, Niemegeers CJ, Janssen PA, Weintraub HS, McKenzie BE . Bromperidol, a new butyrophenone neuroleptic: a review . Psychopharmacology . 78 . 1 . 1–7 . 1982 . 6128755 . 10.1007/BF00470578 . 9465345 .

Notes and References

1. Book: J. Elks . 14 November 2014 . The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies . Springer . 182– . 978-1-4757-2085-3 . 1058412474 .
2. Book: Swiss Pharmaceutical Society . Swiss Pharmaceutical Society . 2000 . Index Nominum 2000: International Drug Directory . Taylor & Francis . 138– . 978-3-88763-075-1 .